Global Molecular Cytogenetics Market Research Report 2023-2030 - Laboratory 4.0 Set to Transform Landscape

News provided by

Oct 23, 2023, 12:30 ET

DUBLIN, Oct. 23, 2023 /PRNewswire/ -- The "Molecular Cytogenetics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global Molecular Cytogenetics Market to Reach $3.5 Billion by 2030

The global Molecular Cytogenetics market, with an estimated value of US$1.8 billion in 2022, is projected to expand to US$3.5 billion by 2030, boasting a compound annual growth rate (CAGR) of 8.7% during the analysis period from 2022 to 2030.

This market encompasses various facets, including Molecular Cytogenetics itself, Consumables, Instruments, Software & Services, as well as techniques like CGH (Comparative Genomic Hybridization), FISH (Fluorescence In Situ Hybridization), Immunohistochemistry, Karyotyping, and other methods. These components find applications in diverse areas such as Genetic Disorders, Cancer, Personalized Medicine, and more.

The Consumables segment, a key element of this market, is anticipated to exhibit a robust CAGR of 8.8%, ultimately reaching a value of US$2 billion at the conclusion of the 8-year analysis period. Meanwhile, the Instruments segment is forecasted to grow at a slightly lower but still substantial CAGR of 7.7% over the next 8 years.

Furthermore, the report delves into the market's utilization across various sectors, including Clinical & Research Laboratories, Pharma & Biotech Companies, Academic Research Institutes, and other applications. These insights, conveyed through tables, offer valuable perspectives on past, present, and future trends within the Molecular Cytogenetics domain.

The U.S. market, with an estimated worth of US$794.6 million in 2022, holds a prominent position within this market. In contrast, China, the world's second-largest economy, is expected to exhibit remarkable growth, with a projected market size of US$231.4 million by 2030, achieving a CAGR of 10% during the analysis period from 2022 to 2030.

This report provides an extensive analysis of the global Molecular Cytogenetics market, furnishing insights into annual revenues, historical patterns, and future forecasts spanning from 2014 to 2030. The analysis is regionally segmented, covering geographic areas such as the USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East, and Africa.

Noteworthy geographic markets include Japan and Canada, both projected to grow at rates of 7.2% and 7.7%, respectively, over the 2022-2030 period. Within Europe, Germany is forecasted to exhibit a substantial CAGR of approximately 8.1%.

In an ever-evolving market landscape, whether it involves emerging entrants like India and South Korea or established leaders such as Abbott Molecular and Thermo Fisher Scientific, it is crucial to monitor all factors impacting the Molecular Cytogenetics market. This vigilance facilitates strategic decision-making to secure and strengthen your position in the market.

What`s New?

Special discussions on the global economic climate and market sentiment
Coverage on global competitiveness and key competitor percentage market shares
Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and trademarked research platform
Complimentary updates for one year
Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

MARKET OVERVIEW

Impact of COVID-19 and a Looming Global Recession
COVID-19 Leaves the World in Shambles & Industries and Markets Upended: World Economic Growth Projections (Real GDP, Annual % Change) for 2019E to 2022F
Challenges and Opportunities for Clinical Diagnostics amid the Pandemic
French Research Team Develops CoronaFISH
Immuno RNA Fluorescence ISH for Visualization of COVID-19 Causing SARS-CoV-2
Molecular Cytogenetics Technologies: An Introductory Prelude
Future Prospects Remain Favorable for Cytogenetics Technologies
Uptrend in Life Sciences R&D and Healthcare Spending Creates Fertile Environment
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
Northbound Trajectory in Med Tech Sector to Generate Parallel Opportunities
Developed Regions: Key Revenue Contributors
Developed Regions Account for Lion's Share of World Molecular Cytogenetics Technologies Market: Percentage Breakdown of Revenues for Developed and Developing Regions (2020E & 2027P)
Fast Paced Growth Projected in Developing Regions
Global Market for Molecular Cytogenetics Technologies - Geographic Regions Ranked by % CAGR (Revenues) for 2020-2027: China, Asia-Pacific, Latin America, USA, Middle East, Africa, Canada, Europe, and Japan
Competitive Scenario
Recent Market Activity
Molecular Cytogenetics - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

MARKET TRENDS & DRIVERS

Critical Importance of Molecular Biology in Laboratory Processes: Cornerstone for Present & Future Growth
Advanced Molecular Biology Techniques Broaden the Scope of Cytogenetics Technologies
Comparative Genome Hybridization (CGH): Largest & Fastest Growing Market Segment
Rising Adoption of Array Based CGH to Spur Overall Demand
Array-based Technologies Continue to Cannibalize Sales from FISH Technology: Percentage (%) Share of Array-Based Solutions in World Cytogenetics Technologies Market (2018 & 2022)
aCGH Simplifies Diagnosis of Chromosomal Anomalies
Clinical Pathological Testing: A Growing Vertical for aCGH
Impact of Rising Emphasis on R&D on Microarray Technology
Leveraging Established Use Case, FISH Technology Continues to Find Favor
Next Generation Sequencing Seeks Role in Cytogenetics Processes
Molecular Cytogenetics Greatly Benefit Cancer Prognosis
Breakdown of Total Number of Cancer Cases by Region: 2020
Breakdown of Total Number of Cancer Cases by Type: 2020
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Cancer Care Made Easier with Highly-Multiplexed FISH
Diverse Applications of FISH Technology in Oncology
Growing Demand for Targeted Therapies in Cancer Treatment Presents Lucrative Opportunities
Increasing Significance of Cytogenetic Analysis in Genetic Disease Diagnosis
Uptrend in Genetic Disease Testing Augments Prospects
List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
Top Ten Genetic Diseases Worldwide
Proven Efficacy in Nucleic Acid Diagnostics Favors Market Growth
Expanding Role of Molecular Cytogenetics in Personalized Medicine
Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
World Personalized Medicine Market by Region/Country (2021): Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific and Rest of World
Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population
Companion Diagnostics Lead the Way to Personalized Medicine
Digitalization, Automation and AI Trends Set to Shape Future Growth
Lab Automation Speeds Up
World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
Laboratory 4.0 Set to Transform Molecular Cytogenetics Landscape
Laboratory Information Systems Gain Traction
Artificial Intelligence : The Future of LIS
Biotech Research Spending Patterns Steer Momentum
Technology Advancements & Improvements Bolster Growth
Ageing Demographics to Drive Demand
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
Technology Overview
A Preface to Cytogenetics
Basic Terms and Definitions in Molecular Biology
An Overview of Select Chromosomal Anomalies
Molecular Cytogenetics
Insight into Molecular Cytogenetics Techniques
Fluorescence in situ Hybridization (FISH)
Comparative Genomic Hybridization (CGH)
Advent of Microarray Technology
Microarrays in Comparative Genomic Hybridization
Principle Underlying aCGH
Low Resolution and High Resolution aCGH
A Review of Molecular Biology Techniques in Cytogenetics

FOCUS ON SELECT PLAYERS (Total 44 Featured)

Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Illumina, Inc.
Abbott Molecular, Inc.
F. Hoffmann-La Roche AG
CytoSport, Inc.
Esperite NV
Eurofins Scientific SE
GeneDx
Empire Genomics LLC
BioDiscovery, Inc.
FUJIFILM Irvine Scientific
ADS Biotec, Inc.
BIOVIEW Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/orw5hk

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets